[1]李亮 陈昱丞 王强 周洁.麻黄附子细辛汤对阳虚型非小细胞肺癌小鼠PI3K/Akt/mTOR信号通路的影响[J].现代中医药,2022,1(02):043-48.[doi:10.13424/j.cnki.mtcm.2022.02.008]
　LI liang CHEN Yucheng WANG Qiang ZHOU Jie.Effect of Mahuang Fuzi Xixin Decoction on PI3K/Akt/mTOR Signal Pathway in Yang Deficiency Non-small Cell Lung Cancer Mice[J].Modern Traditional Chinese Medicine,2022,1(02):043-48.[doi:10.13424/j.cnki.mtcm.2022.02.008]
点击复制

麻黄附子细辛汤对阳虚型非小细胞肺癌小鼠PI3K/Akt/mTOR信号通路的影响
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
1
期数:
2022年02期
页码:
043-48
栏目:
方药纵横
出版日期:
2022-04-16

文章信息/Info

Title:
Effect of Mahuang Fuzi Xixin Decoction on PI3K/Akt/mTOR Signal Pathway in Yang Deficiency Non-small Cell Lung Cancer Mice
文章编号:
1672-0571(2022)02-0043-06
作者:
李亮1 陈昱丞1 王强1 周洁2
1.天津中医药大学第二附属医院中医经典病房，天津 300000；
2.天津中医药大学第二附属医院肿瘤科，天津 300000
Author(s):
LI liang1 CHEN Yucheng1 WANG Qiang1 ZHOU Jie2
1.Traditional Chinese Medicine Classic Ward,Second Affiliated Hospital of Tianjin Universityof Traditional Chinese Medicine,Tianjin 300000,China；
2.Oncology department,Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300000,China
关键词:
关键词：麻黄附子细辛汤; 非小细胞肺癌; PI3K/Akt/mTOR
Keywords:
Key words：Mahuang Fuzi Xixin decoction; Non-small cell lung cancer; PI3K/Akt/mTOR
分类号:
R256.19
DOI:
10.13424/j.cnki.mtcm.2022.02.008
文献标志码:
A
摘要:
摘 要：目的 探讨麻黄附子细辛汤对阳虚型非小细胞肺癌小鼠PI3K/Akt/mTOR信号通路的影响。方法 C57BL/6小鼠按随机分配分为模型组，化疗组，麻黄附子细辛汤高、中、低剂量组（中药高、中、低组），联合组(麻黄附子细辛汤高剂量组+顺铂)，建立阳虚型非小细胞肺癌小鼠模型。造模成功后进行分组给药，采用Western Blot法检测小鼠肿瘤组织PI3K/Akt/mTOR通路相关蛋白表达水平。结果 ①麻黄附子细辛汤、化疗药可减弱PI3K p85a、PI3K p110a蛋白表达水平，暂可认为两药存在交互协同作用；②麻黄附子细辛汤与化疗药物合用对降低Akt、p-Akt蛋白表达具有较明显的协同作用；③麻黄附子细辛汤和顺铂联用对减弱mTOR、p-mTOR蛋白的表达具有协同作用。结论 本实验从整体药效方面探讨麻黄附子细辛汤阻断阳虚型非小细胞肺癌小鼠PI3K/Akt/mTOR信号通路的机制，研究发现麻黄附子细辛汤可一定程度上减弱PI3K、Akt、mTOR蛋白的表达水平，对PI3K/Akt/mTOR信号通路的传导具备一定的抑制功效。
Abstract:
Abstract：Objective To investigate the effect of Mahuang Fuzi Xixin decoction on PI3K/Akt/mTOR signal pathway in Yang deficiency non-small cell lung cancer mice.Methods C57BL/6 mice were randomly divided into model group，chemotherapy group，Mahuang Fuzi Xixin Decoction high，medium and low dose group (traditional Chinese medicine high，medium and low group)，combined group (Mahuang Fuzi Xixin Decoction high dose group+cisplatin).After the successful establishment of the model，the drugs were administered in groups，and the expression level of PI3K/Akt/mTOR pathway related proteins in mouse tumor tissues was detected by Western blot.Results 1.Mahuang Fuzi Xixin decoction and chemotherapeutic drugs can reduce the protein expression levels of PI3K p85a and PI3K p110a.It can be considered that there is interaction and synergy between the two drugs for the time being；2.Mahuang Fuzi Xixin decoction combined with chemotherapy drugs has obvious synergistic effect on reducing the expression of Akt and p-Akt protein；3.The combination of Mahuang Fuzi Xixin decoction and cisplatin has a synergistic effect on weakening the expression of mTOR and p-mTOR proteins.Conclusion This experiment discusses the mechanism of Mahuang Fuzi Xixin decoction blocking PI3K/Akt/mTOR signal pathway in Yang deficiency non-small cell lung cancer mice from the aspect of overall efficacy.It is found that Mahuang Fuzi Xixin decoction can reduce the expression level of PI3K，Akt and mTOR protein to a certain extent，and has a certain inhibitory effect on the transmission of PI3K/Akt/mTOR signal pathway.

参考文献/References:

[1]陆颖,倪伟,赵晓霆,等.从阳虚论治肺积的文献整理及研究概况[J].中华中医药杂志,2019,34(1):291-294.
[2]Thorpe LM,Yuzugullu H,Zhao JJ.PI3K in cancer:divergent roles of isoforms,modes of activation and therapeutic targeting[J].Nature Reviews Cancer,2015,15(1):7-24.
[3]李亮,杜斌,周洁,等.王强主任以麻黄附子细辛汤治疗少阴里虚兼表证非小细胞肺癌思想探析[J].医学信息,2020,33(6):154-155.
[4]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:a Cancer Journal for Clinicians,2018,68(6):394-424.
[5]Cho JH.Immunotherapy for non-small-cell lung cancer:current status and future obstacles[J].Immune Network,2017,17(6):378-391.
[6]Okkenhaug K,Graupera M,Vanhaesebroeck B.Targeting PI3K in cancer:impact on tumor cells,their protective stroma,angiogenesis,and immunotherapy[J].Cancer Discovery,2016,6(10):1090-1105.
[7]Liao Y,Hung MC.Physiological regulation of Akt activity and stability[J].American Journal of Translational Research,2010,2(1):19-42.
[8]Díaz-Serrano A,Angulo B,Dominguez C,et al.Genomic profiling of HER2-positive gastric cancer:PI3K/Akt/mTOR pathway as predictor of outcomes in HER2-positive advanced gastric cancer treated with trastuzumab[J].The Oncologist,2018,23(9):1092-1102.
[9]Firat E,Niedermann G.FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition[J].Oncotarget,2016,7(34):54883-54896.
[10]Breitkopf SB,Yang XM,Begley MJ,et al.A cross-species study of PI3K protein-protein interactions reveals the direct interaction of P85 and SHP2[J].Scientific Reports,2016,6:20471.
[11]高胜东,戴蓉,周钊.LncRNA CRNDE激活PI3K/Akt通路促进非小细胞肺癌细胞增殖、迁移及侵袭[J].生物医学工程与临床,2021,25(1):85-91.
[12]吴昊,魏吉红,郑瑾,等.论阳虚与肿瘤形成的关系[J].中华中医药杂志,2017,32(3):969-971.
[13]张元兵,王丽华,李少峰,等.从阳虚痰凝流注论治肺腺癌初探[J].江西中医药,2020,51(10):11-13.
[14]李亮,周洁.浅谈阳虚和肿瘤[J].中医药信息,2012,29(6):6-7.
[15]李仲普,胡学军,冯磊,等.阳和汤抑制阳虚证小鼠Lewis肺癌生长的实验研究[J].中医药导报,2017,23(9):25-29.
[16]Feng HT,Zhao WW,Lu JJ,et al.Hypaconitine inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses adhesion,migration,and invasion of lung cancer A549 cells[J].Chinese Journal of Natural Medicines,2017,15(6):427-435.
[17]王楚慰.温阳附子汤治疗肺癌咳血患者的临床观察[J].深圳中西医结合杂志，2015,25(9):168-169.
[18]黄颖,周洁.周洁教授巧用温阳法治疗恶性肿瘤化疗副反应的经验[J].内蒙古中医药,2018,37(5):28-29.
[19]钦敬茹,徐祖红,王中奇.王中奇老师运用麻黄附子细辛汤治疗肺癌经验[J].吉林中医药,2018,38(4):402-404,408.
[20]杨露,谢晓芳,郑川,等.麻黄附子细辛汤联合紫杉醇诱导A549/T细胞凋亡的研究[J].中药药理与临床,2015,31(3):11-13.
[21]张梦凡.张林军运用桂枝去芍药加麻黄附子细辛汤加减治疗肿瘤的经验[J].中医临床研究,2020,12(24):3-5.
[22]朱芳.麻黄附子细辛汤治疗肺癌疼痛临床观察[J].中国中医药现代远程教育,2021,19(3):101-103.

相似文献/References:

[1]张莉莉 董媛.益气养精法联合化疗治疗非小细胞肺癌疗效[J].现代中医药,2021,(01):095.[doi:10.13424/j.cnki.mtcm.2021.01.023]
[2]胡序 席孝忠.自拟扶正益气化痰方辅助治疗晚期非小细胞肺癌患者的效果及对免疫功能的影响[J].现代中医药,2021,(04):095.[doi:10.13424/j.cnki.mtcm.2021.04.022]
[3]胡亚琪高磊 郝万山 姜敏.“黄芪半夏”药对治疗非小细胞肺癌 作用机制研究[J].现代中医药,2023,(03):106.[doi:10.13424/j.cnki.mtcm.2023.03.020]
　HU Yaqi GAO Lei HAO Wanshan JIANG Min.Exploration of Action Mechanism of “Huangqi-Banxia”Drug Pair in Treatment of Nonsmall Cell Lung Cancer[J].Modern Traditional Chinese Medicine,2023,(02):106.[doi:10.13424/j.cnki.mtcm.2023.03.020]

备注/Memo

备注/Memo:
基金项目：天津市教委科研计划项目（2019KJ069）
更新日期/Last Update: 2022-04-08